Voriconazole-related severe adverse events: clinical application of therapeutic drug monitoring in Korean patients

Abstract

This study shows that therapeutic drug monitoring is indicated in patients with a voriconazole-related SAE and that dose adjustment is required if the trough concentration of voriconazole exceeds 5.83 mg/l.